[No authors listed]. Monograph. Valeriana officinalis. Altern Med Rev. 2004 Dec;9(4):438-41.
Abumaria N, Yin B, Zhang L, et al. Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity in the infralimbic prefrontal cortex and lateral amygdala. J Neurosci. 2011 Oct 19;31(42):14871-81.
Al-Shamma HA, Anderson C et al. Nelotanserin, a Novel Selective 5-Hydroxytryptamine2A Inverse Antagonist for the Treatment of Insomnia. The Journal of Pharmacology and Experimental Therapeutics, 2010; 332(1): 281-90.
American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Revised. 2001.
Ancoli-Israel S, Krystal AD et al. A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia. Sleep, 2010; 33(2): 225-234.
Ancoli-Israel S, Walsh JK et al. Zaleplon, A Novel Nonbenzodiazpeine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects. Primary Care Companion, 1999; 1(4): 114-120.
Anderson GD, Elmer GW et al. Pharmacokinetics of Valerenic Acid After Single and Multiple Doses of Valerian in Older Women. Phytotherapy Research, 2010; 24: 1142-6.
Appel K, Rose T, Fiebich B, et al. Modulation of the γ-aminobutyric acid (GABA) system by Passifloraincarnata L. Phytother Res. 2011 Jun;25(6):838-43. doi: 10.1002/ptr.3352.
Archana R and Namasivayam A. Antistressor Effect of Withania somnifera. Journal of Ethnopharmacology, 1999; 64; 91-93.
Aronsohn RS, Whitmore H et al. Impact of Untreated Obstructive Sleep Apnea on Glucose control in Type 2 Diabetes. American Journal of Respiratory Critical Care, 2010; 181; 507-513.
Aurón Zaltzman D. [Amitriptyline hydrochloride in the treatment of anxiety and insomnia and as a tranquilizer]. NeurolNeurocirPsiquiatr. 1976;17(3):165-9.
Baroni A, Hernandez M, Grant MC, Faedda GL. Sleep Disturbances in Pediatric Bipolar Disorder: A Comparison between Bipolar I and BipolarNOS. Front Psychiatry. 2012;3:22. Epub 2012 Mar 20.
Barrett-Connor E, Dam TT, Stone K, et al. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J ClinEndocrinolMetab. 2008 Jul;93(7):2602-9.
Bastien CH, St-Jean G, et al. Chronic Psychophysiological Insomnia: Hyperarousal and/or Inhibition Deficits? An ERPs Investigation. Sleep, 2008; 31(6): 887-98.
Bercovitch RS and Tsai SC. Respiratory Medications and Sleep. Current Respiratory Care Report, 2012: 123-30.
Bhattacharya SK, Bhattacharya A et al. Anxiolytic/Antidepressant Activity of WithaniaSomniferaGlycowithanolides: an Experimental Study. Phytomedicine, 2000; 7(6): 463-9.
Bonnet MH and Arand DL. Hyperarousal and Insomnia: State of the Science. Sleep Medicine Reviews, 2010;14:9-15.
Borja NL and Daniel KL. Ramelteon for the Treatment of Insomnia. Clinical Therapeutics, 2006; 28(10): 1540-55.
Brower KJ, Myra Kim H, Strobbe S, et al. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. oholClinExp Res. 2008 Aug;32(8):1429-38.
Buscemi N, Vandermeer B et al. The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-Analysis of RCTS. Journal of General Internal Medicine, 2007; 22: 1335-50.
Butcher SK, Killampalli V, Lascelles D, et al. Raised cortisol:DHEAS ratios in the elderly after injury: potential impact upon neutrophil function and immunity. Aging Cell. 2005 Dec;4(6):319-24.
Buysse DJ, Germain A et al. Diagnosis, Epidemiology and Consequences of Insomnia. Primary Psychiatry, 2005; 12(8): 37-44.
Canguven O, Salepci B, Albayrak S, et al. Is there a correlation between testosterone levels and the severity of the disease in male patients with obstructive sleep apnea? Arch ItalUrolAndrol. 2010 Dec;82(4):143-7.
Cardinali DP, Srinivasan V et al. Melatonin and its Analogs in Insomnia and Depression. Journal of Pineal Research, 2012; 52: 365-75.
Chien KL, Chen PC, Hsu HC, et al. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Sleep. 2010 Feb;33(2):177-84.
Chien LW, Cheng SL et al. The Effect of Lavendar Aromatherapy on Autonomic Nervous System in Midlife Women with Insomnia. Evidence Based Complementary and Alternative Medicine, 2012: 1-8.
Chiodini I, Scillitani A. [Role of cortisol hypersecretion in the pathogenesis of osteoporosis]. RecentiProg Med. 2008 Jun;99(6):309-13.
Cluydts R. A Breakthrough in the Pharmacological Management of Insomnia: Overview of the Clinical Profile of Zaleplon. Primary Care Companion, 2002; 4: 46-8.
Dahwan K, Dhawan S et al. Passiflora: A Review Update. Journal of Ethnopharmacology, 2004; 94: 1-23.
Dahwan K, Kumar S et al. Comparative Anxiolytic Activity Profile of Various Preparations of Passiflora incarnate Linneaus: A Comment on Medicinal Plants' Standardization. The Journal of Complementary and Alternative Medicine, 2002; 8(3): 283-91.
Dhawan K, Dhawan S, and Chhabra S. Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety of PassifloraincarnataLinneaus: a non-habit forming anxiolytic. J Pharm Pharm Sci. 2003 May-Aug;6(2):215-22.
Drager LF, PolotskyVY et al. Obstructive Sleep Apnea: An Emerging Risk Factor for Atherosclerosis. Chest, 2011; 140: 534-42.
Duong M, Cohen JI, and Convit A. h cortisol levels are associated with low quality food choice in type 2 diabetes. Endocrine. 2012 Feb;41(1):76-81.
Durlach J, Pagès N, Bac P, et al. Biorhythms and possible central regulation of magnesium status, phototherapy, darkness therapy and chronopathological forms of magnesium depletion. Magnes Res. 2002 Mar;15(1-2):49-66.
Ellis JG, Gehrman P, Espie CA, et al. Acute insomnia: current conceptualizations and future directions. Sleep Med Rev. 2012 Feb;16(1):5-14.
Erman M, Seiden D et al. An Efficacy, Safety and Dose-Response Study of Ramelteon in Patients with Chronic Primary Insomnia. Sleep Medicine, 2006; 7: 17-24.
Espie CA. Insomnia: Conceptual Issues in the Development, Persistence and Treatment of Sleep Disorder in Adults. Annual Reviews in Psychology, 2002; 53: 215-43.
Fernandez-San-Martin MI, Masa-Font R et al. Effectiveness of Valerian on Insomnia: A Meta-Analysis of Randomized Control Trials. Sleep Medicine, 2010; 11: 505-11.
Galecki P, ski A, Talarowska M. et al. [Efficacy of trazodone in the treatment of insomnia]. Pol MerkurLekarski. 2010 Jun;28(168):509-12.
Garfinkel D, Zorin M et al. Efficacy and Safety of Prolonged-Release Melatonin in Insomnia Patients with Diabetes: A Randomized, Double-Blind, Crossover Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2011; 4: 307-13.
Geijlswijk IM, Heijden KB et al. Dose Finding of Melatonin for Chronic Idiopathic Childhood Onset Insomnia: a RCT. Psychopharmacology, 2010; 212: 379-91.
George CF. Perspectives on the management of insomnia in patients with chronic respiratory disorders. Sleep. 2000 Feb 1;23 Suppl1:S31-5; discussion S36-8.
Geyer JD, Ruiter ME et al. Management of Insomnia in Patients with Chronic Obstructive Pulmonary Disease. Sleep Medicine Clinics, 2008: 379-87.
Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart healthy study. Circulation. 2010;122(4):352-60.
Gutierrez S, Ang-Lee MK, Walker DJ, et al. Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers. PharmacolBiochemBehav. 2004 May;78(1):57-64.
Hajak G, Huether G, Blanke J, et al. The influence of intravenous L-tryptophan on plasma melatonin and sleep in men. Pharmacopsychiatry. 1991 Jan;24(1):17-20.
Hammoud AO, Walker JM et al. Sleep Apnea, Reproductive Hormones and Quality of Sexual Life in Severely Obese Men. Obesity, 2011; 19(6): 1118-1123.
Hartmann E, Cravens J et al. Hypnotic Effects of L-Tryptophan. Archives of General Psychiatry, 1974; 31: 394-7.
Hendler RA, Ramchandani VA, Gilman J, et al. Stimulant and Sedative Effects of Alcohol. Curr Top BehavNeurosci. 2013; 13: 489-509. doi: 10.1007/7854_2011_135.
Hindmarch I, Legangeneux E et al. A Double-Blind, Placebo-Controlled Investigation of the Residual Psychomotor and Cognitive Effects of Zolpidem-MR in Healthy Elderly Volunteers. British Journal of Pharmacology, 2006; 62(5): 538-45.
Hirokawa K, Nishimoto T et al. Effects of Lavender Aroma on Sleep Quality in Healthy Japanese Students. Perceptual and Motor Skills, 2012; 114(1): 111-122.
Hoch CC, Reynolds CF et al. Protecting Sleep Quality in Later Life: A Pilot Study of Bed Restriction and Sleep Hygiene. Journal of Gerontology, 2001; 56 (1): P52-9.
Holbrook AM, Crowther R et al. Meta-analysis of Benzodiazepine Use in the Treatment of Insomnia. Canadian Medical Association Journal, 2000; 162(2): 225-33.
Hoque R and Chesson AL. Zolpidem-Induced Sleepwalking, Sleep Related Eating Disorder and Sleep-Driving. Fluorine-18 Positron Emission Tomography Analysis, and a Literature Review of Other Unexpected Clinical Effects of Zolpidem. Journal of Clinical Sleep Medicine, 2009; 5(5): 471-6.
Hornyak M, Voderholzer U, Hohagen F, et al. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep. 1998 Aug 1;21(5):501-5.
Hublin C, Partinen M, Koskenvuo M, et al. Heritability and mortality risk of insomnia-related symptoms: a genetic epidemiologic study in a population-based twin cohort. Sleep. 2011 Jul 1;34(7):957-64.
Huss M, Volp A, and Stauss-Grabo M. upplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - an observational cohort study. Lipids Health Dis. 2010 Sep 24;9:105.
Irwin MR, Wang M et al. Sleep Deprivation and Activation of Morning Levels of Cellular and Genomic Markers of Inflammation. Archives of Internal Medicine, 2006; 166: 1756-1762.
Jaehne A, Loessl B et al. Effects of Nicotine on Sleep During Consumption, Withdrawal, and Replacement Therapy. Sleep Medicine Reviews, 2009; 13: 363-77.
Kakizaki M, Inoue K, Kuriyama S, et al. Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer. 2008 Jul 8;99(1):176-8. Epub 2008 Jun 10.
Kato K, Hirai K et al. Neurochemical Properties of Ramelteon (TAK-375), a Selective MT1/Mt2 Receptor Agonist. Neuropharmacology, 2005; 48: 301-10.
Katz DA and McHorney CA. Clinical Correlates of Insomnia in Patients with Chronic Illness. Archives of Internal Medicine, 1998; 158: 1099-107.
Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med, 2004; 66(4): 607-13.
Kessler RC, Berglund PA et al. Insomnia and the Performance of US Workers: Results from the American Insomnia Survey. Sleep, 2011; 34(9): 1161-1171.
Kim JH, Desor D et al. Efficacy of as1-casein hydrolysate on stress-related symptoms in women. European Journal of Clinical Nutrition, 2007; 61: 536-541.
Kolla BP and Auger RR. Jet Lag and Shift Work Sleep Disorders: How to Help Reset the Internal Clock. Cleveland Clinic Journal of Medicine, 2011; 78(10): 675-84.
Kripke DF, Langer RD, and Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open. 2012 Feb 27;2(1):e000850. Print 2012.
Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007 Aug 21;7:42.
Krystal AD, Durrence HH et al. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Primary Insomnia. Sleep, 2010: 33(11): 1553-61.
Krystal AD, Erman M et al. Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg. Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients with Chronic Primary Insomnia: A 6-month, Randomized, Double-Blind, Placbo-Controlled, Parallel-Group Multi-Center Study. Sleep, 2008; 31(1): 79-90.
Kumar A and Kalonia H. Protective effect of WithaniasomniferaDunal on the behavioral and biochemical alterations in sleep-disturbed mice (Grid over water suspended method). Indian J Exp Biol. 2007 Jun;45(6):524-8.
Kumar a, Kalonia H. Effect of Withania somnifera on Sleep-Wake Cycle in Sleep-Disturbed Rats: Possible GABAergic Mechanism. Indian J Pharm Sci. 2008;70(6):806-10.
Lande RG and Gragnani C. Nonpharmacological Approaches for the Treatment of Insomnia. The Journal of the American Osteopathic Association, 2010; 110(12): 695-701.
Landolt HP and Wehrle R. Antagonism of serotonergic 5-HT2A/2C receptors: mutual improvement of sleep, cognition and mood? Eur J Neurosci. 2009 May;29(9):1795-809.
Lemoine P, Wage AG et al. Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials. Integrated Blood Pressure Control, 2012; 5: 9-17.
Lewith GT, Godfrey AD et al. A Single-Blinded, Randomized Pilot Study Evaluating the Aroma of Lavandulaaugustifolia as a Treatment for Mild Insomnia. The Journal of Alternative and Complementary Medicine, 2005; 11(4): 631-7.
Lieberman JA. Update on the Safety Considerations in the Management of Insomnia with Hypnotics: Incorporating Modified-Release Formulations Into Primary Care. Primary Care Companion, 2007; 9(1): 25-31.
Mastin DF, Bryson J, Corwyn R. Assessment of sleep hygiene using the Sleep Hygiene Index. J Behav Med. 2006;29(3):223-7.
McCurry SM, Logsdon RG, Teri L, et al. Sleep disturbances in caregivers of persons with dementia: contributing factors and treatment implications. Sleep Med Rev. 2007;11(2):143-53.
Mendelson WB. A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia. Journal of Clinical Psychiatry, 2005; 66: 469-76.
Mills EJ, Wu P et al. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tobacco Induced Diseases, 2010; 8(8): 8.
Miyamoto M. [A novel therapeutic drug: ramelteon]. Nihon Rinsho. 2009 Aug;67(8):1595-600.
Moghadam-Kia S and WerthVp et al. Prevention and Treatment of Systemic Glucocorticoid Side Effects. International Journal of Dermatology, 2010; 49: 239-48.
Morin CM, LeBlanc M et al. Epidemiology of Insomnia: Prevalence, Self-Help Treatments, Consultations and Determinants of Self-Help Seeking Behaviors. Sleep Medicine, 2006: 123-30.
Muller SF and Klement S. A Combination of Valerian and Lemon Balm is Effective in the Treatment of Restlessness and Dyssomnia in Children. Phytomedicine, 2006; 13: 383-7.
Nassiri-Asl M, Shariati-Rad S et al. Anticonvulsant Effects of Arial Parts of Passifloraincarnata Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors. BMC Complementary and Alternative Medicine, 2007; 8(7): 26.
National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH). Facts About Insomnia. October 1995. Available at: http://www.nhlbi.nih.gov/health/public/sleep/insomnia.txt. Accessed 6/14/2012.
Neikrug AB and Ancoli-Israel S. Sleep Disorders in the Older Adult-A Mini Review. Gerontology, 2010; 56: 181-9.
Nerbass FB, Pedrosa RP et al. Calcium Channel Blockers are Independently Associated With Short Sleep Duration in Hypertensive Patients with Obstructive Sleep Apnea. Journal of Hypertension, 2011; 29(6): 1236-41.
Nieto FJ, Peppard PE, Young T, et al. Sleep disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J RespirCrit Care Med. 2012 May 20. [Epub ahead of print]
Nonogaki K. Serotonin conflict in sleep-feeding. VitamHorm. 2012;89:223-39.
Ochoa-Sanchez R, Comai S et al. Promotion of Non-Rapid-Eye-Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand. Journal of Neuroscience, 2011; 31(50): 18439-18452.
Ohayon MM, Caulet M, Lemoine P. Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry. 1998 Jul-Aug;39(4):185-97.
Omiya K, Akashi YJ, Yoneyama K, et al. Heart-rate response to sympathetic nervous stimulation, exercise, and magnesium concentration in various sleep conditions. Int J Sport NutrExercMetab. 2009 Apr;19(2):127-35.
Paredes SD, Barriga CM et al. Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-Wake Cycle and Immune Function: Streptopeliarisioria as a Model. International Journal of Tryptophan Research, 2009a; 2: 23-36.
Paredes SD, Marchena AM et al. Rhythm, Core and Peripheral Temperatures and Interleukin Levels in the Ringdove: Changes with Age. Journal of Gerontology, 2009b; 64A(3): 340-50.
Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive Sleep Apnea: The Most Common Secondary Cause of Hypertension Associated with Resistant Hypertension. Hypertension, 2011; 58:811-817.
Peuhkuri K, Sihvola N, and Korpela R. Diet promotes sleep duration and quality. Nutr Res. 2012 May;32(5):309-19.
Philips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med. 2007 Aug 15;3(5):489-94.
Punjabi NM. The Epidemiology of Adult Obstructive Sleep Apnea. Proc Am ThoracSoc, 2008; 5(2):136-43.
Raines T, Jones P et al. Investigation of the Anxiolytic Effects of Luteolin, A Lemon Balm Flavonoid in the Male Sprague-Dawley Rat. AANA Journal, 2009; 77(1): 33-36.
Randall S, Roehrs TA et al. Over-the-Counter Sleep Aid Medications and Insomnia. Primary Psychiatry, 2008; 15(5): 52-58.
Richard DM, Dawes MA et al. L-Tryptophan: Basic Metabolic Functions, Behavioral research and Therapeutic Indications. International Journal of Tryptophan Research, 2009; 2: 45-60.
Roehrs T and Roth T. Caffeine: Sleep and Daytime Sleepiness. Sleep Medicine Reviews, 2008; 12: 153-62.
Rondanelli M, Opizzi A et al. The Effect of Melatonin, Magnesium and Zinc on Primary Insomnia in Long-Term Care Facility Residents in Italy: A Double-Blind, Placebo-Controlled Clinical Trial. Journal of the American Geriatric Society, 2011; 59: 82-90.
Roth T and Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone. 2003;5(3):5-15.
Roth T, Rogowski R et al. Efficacy and Safety of Doxepin 1 mg, 3 mg and 6 mg in Adults With Primary Insomnia. Sleep, 2007; 30(11): 1557-64.
Roth T, Walsh JK et al. An Evaluation of the Safety and Efficacy of Eszopiclone over 12 Months in Patients with Chronic Primary Insomnia. Sleep Medicine, 2005; 6(6): 487-95.
Saint-Hilaire Z, Messaoudi M et al. Effects of a Bovine Alpha S1-Casein TrypticHydrosylate (CTH) on Sleep Disorder in Japanese General Population. The Open Sleep Journal, 2009; 2: 26-32.
Saletu-Zyhlarz G, Anderer P et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen–progestogen combination (Climodien_, Lafamme_) versus estrogen alone. Journal of Sleep Research, 2003; 12: 239-54.
Sanchez-Ortuno MM, Bélanger L, Ivers H, et al. The use of natural products for sleep: A common practice? Sleep Med. 2009 Oct;10(9):982-7.
Sateia MJ, Kirby-Long P, Taylor JL. Efficacy and clinical safety of ramelteon: an evidence-based review. Sleep Med Rev. 2008;12(4):319-32.
Sato M, Yamadera W et al. Clinical Efficacy of Individual Cognitive Behavior Therapy for Psychophysiological Insomnia in 20 Outpatients. Psychiatry and Clinical Neurosciences, 2010; 64: 187-195.
Schewitzer PK, Curry Dt et al. Pharmacological treatment of Insomnia. Clinical Handbook of Insomnia, 2010: 297-316.
Shatzmiller RA and Benbadis SR. Insomnia. Available at: http://emedicine.medscape.com/article/1187829-overview Revised 2/12/2012; Accessed 4/19/2012.
Shinomiya K, Inoue T et al. Hypnotic Effects of Chamomile and Passiflora Extracts in Sleep-Disturbed Rats. Biological Pharmacology Bulletin, 2005; 28(5): 808-10.
Silber BY and Schmitt JA. Effects of Tryptophan Loading on Human Cognition, Mood and Sleep. NeurosciBiobehav Rev, 2010; 34: 387-407.
Silva BH, Martinez D et al. A Randomized, Controlled Pilot Trial of Hormone Therapy for Menopausal Insomnia. Archives of Women's Mental Health, 2011; 14: 505-8.
Singareddy R, Vgontzas AN et al. Risk Factors for Incident Chronic Insomnia: A General Population Prospective Study. Sleep Medicine, 2012: 346-53.
Sivertsen B, Krokstad S et al. The Epidemiology of Insomnia: Associations with Physical and Mental Health. Journal of Psychosomatic Research, 2009: 109-116.
Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010 Jan 28;65(2):165-77.
Smith MT, Quartana PJ et al. Mechanisms By Which Sleep Disturbance Contributes to Osteoarthritic Pain: A Conceptual Model. Current Pain and Headache Reports, 2009; 13: 447-54.
Song CH, Kim YH et al. Associations of Zinc and Copper Levels in Serum and Hair with Sleep Duration in Young Women. Biological Trace Element Research, 2012.
Spadoni G, Bedini A et al. Melatonin Receptor Agonists: New Options for Insomnia and Depression Treatment. CNS Neuroscience and Therapeutics, 2011; 17: 733-41.
Taylor DJ, Mallory LJ et al. Comorbidity of Chronic Insomnia with Medical Problems. Sleep, 2007; 30(2): 213-8.
Terauchi M, Hiramitsu S, Akiyoshi M, et al. Associations between anxiety, depression and insomnia in peri- and post-menopausal women. Maturitas. 2012 May;72(1):61-5.
Turek FT and Gilette MU. Melatonin, Sleep and Circadian Rhythms: Rationale for Development of Specific Melatonin Agonists. Sleep Medicine, 2005; 5: 523-32.
UAB News. [Lollar J.] Sleep debt hikes risk of stroke symptoms despite healthy BMI. 6/11/2012 Available at: http://www.uab.edu/news/latest/item/2483-sleep-debt-hikes-risk-of-stroke-symptoms-despite-healthy-bmi?tmpl=component&print=1 Accessed 6/21/2012.
Verkasalo PK, Lillberg K, Stevens RG, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005 Oct 15;65(20):9595-600.
Walsh JK, Erman M et al. Subjective Hypnotic Efficacy of Trazodone and Zolpidem in DSMRIII-R Primary Insomnia. Human Psychopharmacology, 1998; 13: 191-198.
Weber J, Siddiqui MA, WagstaffAJ, et al. Low-dose doxepin: in the treatment of insomnia. CNS Drugs. 2010 Aug;24(8):713-20.
Weeks BS. Formulations of Dietary Supplements and Herbal Extracts for Relaxation and Anxiolytic Action: Relarian. Medical Science Monitor, 2009; 15(11): 256-62.
Woods NF and Mitchell ES. Symptoms During the Perimenopause: Prevalence, Severity Trajectory, and Significance in Women's Lives. The American Journal of Medicine, 2005; 118: 14-24.
Xiong Y, Ullman B et al. Synthesis and in Vivo Evaluation of Phenethylpiperazine Amides: Selective 5-HydroxyTryptamine2A Receptor Antagonists for the Treatment of Insomnia. Journal of Medicinal Chemistry, 2010; 53: 5696-706.
Xu J, Jiang X et al. Propofol-Induced Sleep: Efficacy and Safety in Patients with Refractory Chronic Insomnia. Cell BiochemBiophys, 2011 Jul;60(3): 161-6.
Yaggi HK, Concato J. Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. The New England Journal of Medicine, 2005; 353(19): 2034-41.
Yang CM and Lin SC. Maladaptive Sleep Hygiene Practices in Good Sleepers and Patients with Insomnia. Journal of Health Psychology, 2010; 15(1): 147-55.
Youngberg MR, Karpov IO et al. Clinical and Physiological Correlates of Caffeine and Caffeine Metabolites in Primary Insomnia. J Clin Sleep Med. 2011;7(2):196-203.
Zammit G, Erman M et al. Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia. Journal of Clinical Sleep Medicine, 2007; 3(5): 495-504.
Zhang J, Ma RC et al. Relationship of Sleep Quantity and Quality with 24-Hour Urinary Catecholamines and Salivary Awakening Cortisol in Healthy Middle-Aged Adults. Sleep, 2011; 34(2): 225-233.
Zick SM, Wright BD et al. Preliminary Examination of the Efficacy of Safety of a Standardized Chamomile Extract for Chronic Primary Insomnia: A Randomized Placebo-Controlled Pilot Study. BMC Complementary and Alternative Medicine, 2011; 11: 78.
Ziegler G, Ploch M, Miettinen-Baumann A, et al. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. Eur J Med Res. 2002 Nov 25;7(11):480-6.